Floatz logo

Florbetaben

Temporal Lobe Epilepsy (TLE)

University of MinnesotaSmall moleculeDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

4 Active assets in the Temporal Lobe Epilepsy (TLE) cohort.

Asset / SponsorPhaseRating
Nrtx-1001
Neurona Therapeutics
Phase 3BB
NALUZOTAN
National Institute of Neurological Disorders and Stroke (NINDS)
Phase 2CCC
Ferumoxytol
University of Alberta
Phase 2CCC
aav9-hsyn1-migrik2
UniQure Biopharma B.V.
Phase 1/2CCC
Ux-Gip001
Second Affiliated Hospital, School of Medicine, Zhejiang University
Early Phase 1C

Same molecule, other indications

Florbetaben is also rated in:

Cardiac AmyloidosisDormant
BBB
Indicative ·
73 / 100
View asset →
Alzheimer diseaseDormant
BBB
Indicative ·
72 / 100
View asset →
Amyloid Beta-ProteinDormant
BB
Indicative ·
64 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →